Technical Analysis for BHVN - Biohaven Pharmaceutical Holding Company Ltd.

Grade Last Price % Change Price Change
grade C 26.93 1.35% 0.36
BHVN closed up 1.35 percent on Wednesday, January 17, 2018, on approximately normal volume.
1 Watcher
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Down
See historical BHVN trend table...

Date Alert Name Type % Chg
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 16 Stochastic Reached Oversold Weakness 1.35%
Jan 16 Wide Bands Range Expansion 1.35%
Jan 16 Oversold Stochastic Weakness 1.35%
Jan 12 MACD Bearish Signal Line Cross Bearish 1.85%
Jan 12 50 DMA Support Bullish 1.85%
Jan 12 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.85%
Jan 12 Wide Bands Range Expansion 1.85%
Jan 12 Oversold Stochastic Weakness 1.85%

Older signals for BHVN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Biohaven Pharmaceutical Holding Company Ltd. is a United States-based biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. It has a portfolio of multiple late-stage drug candidates. Its pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity (NCE) that modulates glutamate, and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate (NMDA) receptor antagonism. Its clinical compound, trigriluzole, is indicated for neurodegenerative diseases and cancer indications, among others. Its pipeline also includes BHV-3000 and BHV-3500, which are in-licensed by the Company for a neurologic indication. It focuses on advancing other mechanistic approaches in orphan and neuroscience indications, and is exploring licenses for additional compounds.
Is BHVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.51
52 Week Low 17.0
Average Volume 355,080
200-Day Moving Average 0.0
50-Day Moving Average 25.6112
20-Day Moving Average 27.3975
10-Day Moving Average 28.037
Average True Range 1.4557
ADX 26.16
+DI 21.04
-DI 26.19
Chandelier Exit (Long, 3 ATRs ) 26.2829
Chandelier Exit (Short, 3 ATRs ) 25.9271
Upper Bollinger Band 30.4707
Lower Bollinger Band 24.3243
Percent B (%b) 0.42
BandWidth 22.434164
MACD Line 0.5155
MACD Signal Line 0.7165
MACD Histogram -0.201
Fundamentals Value
Market Cap 965.38 Million
Num Shares 35.8 Million
EPS -7.54
Price-to-Earnings (P/E) Ratio -3.57
Price-to-Sales 0.00
Price-to-Book 5.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.33
Resistance 3 (R3) 29.17 28.20 28.93
Resistance 2 (R2) 28.20 27.59 28.29 28.80
Resistance 1 (R1) 27.57 27.21 27.89 27.73 28.66
Pivot Point 26.60 26.60 26.76 26.69 26.60
Support 1 (S1) 25.97 25.99 26.29 26.13 25.20
Support 2 (S2) 25.00 25.61 25.09 25.06
Support 3 (S3) 24.37 25.00 24.93
Support 4 (S4) 24.53